Sisignano M, Baron R, Scholich Ok, Geisslinger G. Mechanism-based remedy for chemotherapy-induced peripheral neuropathic ache. Nat Rev Neurol. 2014;10:694–707.
Flatters SJL, Dougherty PM, Colvin LA. Medical and preclinical views on chemotherapy-induced peripheral neuropathy (CIPN): a story evaluate. Br J Anaesth. 2017;119:737–49.
Colvin LA. Chemotherapy-induced peripheral neuropathy: the place are we now? Ache. 2019;160(Suppl 1):S1–10.
Kim JH, Dougherty PM, Abdi S. Primary science and scientific administration of painful and non-painful chemotherapy-related neuropathy. Gynecol Oncol. 2015;136:453–9.
Kirksey MA, Haskins SC, Cheng J, Liu SS. Native anesthetic peripheral nerve block adjuvants for prolongation of analgesia: a scientific qualitative evaluate. PLoS ONE. 2015;10: e0137312.
Ventham NT, Hughes M, O’Neill S, Johns N, Brady RR, Wigmore SJ. Systematic evaluate and meta-analysis of steady native anaesthetic wound infiltration versus epidural analgesia for postoperative ache following stomach surgical procedure. Br J Surg. 2013;100:1280–9.
Gupta A. Wound infiltration with native anaesthetics in ambulatory surgical procedure. Curr Opin Anaesthesiol. 2010;23:708–13.
Waldinger R, Weinberg G, Gitman M. Native anesthetic toxicity within the geriatric inhabitants. Medication Getting old. 2020;37:1–9.
Roberson DP, Binshtok AM, Blasl F, Bean BP, Woolf CJ. Concentrating on of sodium channel blockers into nociceptors to provide long-duration analgesia: a scientific examine and evaluate. Br J Pharmacol. 2011;164:48–58.
Chen S, Yao W, Wang H, Wang T, Xiao X, Solar G, Yang J, Guan Y, Zhang Z, Xia Z, et al. Injectable electrospun fiber-hydrogel composite sequentially releasing clonidine and ropivacaine for extended and strolling regional analgesia. Theranostics. 2022;12:4904–21.
Zhao ZQ, Zhang BL, Chu HQ, Liang L, Chen BZ, Zheng H, Guo XD. A high-dosage microneedle for programmable lidocaine supply and enhanced native long-lasting analgesia. Biomater Adv. 2022;133: 112620.
Ke P, Qin Y, Shao Y, Han M, Jin Z, Zhou Y, Zhong H, Lu Y, Wu X, Zeng Ok. Preparation and analysis of liposome with ropivacaine ion-pairing in native ache administration. Drug Dev Ind Pharm. 2022;48:255–64.
Wadhawan A, Chatterjee M, Singh G. Current state of affairs of bioconjugates in most cancers remedy: a evaluate. Int J Mol Sci. 2019;20:5243.
Weinberg BD, Blanco E, Gao J. Polymer implants for intratumoral drug supply and most cancers remedy. J Pharm Sci. 2008;97:1681–702.
Lu B, Solar L, Yan X, Ai Z, Xu J. Intratumoral chemotherapy with paclitaxel liposome mixed with systemic chemotherapy: a brand new methodology of neoadjuvant chemotherapy for stage III unresectable non-small cell Lung most cancers. Med Oncol. 2015;32:345.
Walter KA, Tamargo RJ, Olivi A, Burger PC, Brem H. Intratumoral chemotherapy. Neurosurgery. 1995;37:1128–45.
Yang L, Wang B, Qiao W, Liu P. A novel mixture chemotherapy integrating with intratumoral chemotherapy. Med Hypotheses. 2009;73:334–5.
Celikoglu F, Celikoglu SI, Goldberg EP. Bronchoscopic intratumoral chemotherapy of lung most cancers. Lung Most cancers. 2008;61:1–12.
Duvillard C, Polycarpe E, Romanet P, Chauffert B. [=Intratumoral chemotherapy: experimental data and applications to head and neck tumors. Ann Otolaryngol Chir Cervicofac. 2007;124:53–60.
Ta HT, Dass CR, Dunstan DE. Injectable chitosan hydrogels for localised cancer therapy. J Control Release. 2008;126:205–16.
Wolinsky JB, Colson YL, Grinstaff MW. Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. J Control Release. 2012;159:14–26.
Huang P, Wang X, Liang X, Yang J, Zhang C, Kong D, Wang W. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy. Acta Biomater. 2019;85:1–26.
Blanco E, Kessinger CW, Sumer BD, Gao J. Multifunctional micellar nanomedicine for cancer therapy. Exp Biol Med. 2009;234:123–31.
Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2:751–60.
Cattel L, Ceruti M, Dosio F. From conventional to stealth liposomes: a new Frontier in cancer chemotherapy. J Chemother. 2004;16(Suppl 4):94–7.
Lake DE, Hudis CA. High-dose chemotherapy in breast cancer. Drugs. 2004;64:1851–60.
Zraik IM, Hess-Busch Y. Management of chemotherapy side effects and their long-term sequelae. Urologe A. 2021;60:862–71.
Ha H, Lim JH. Managing side effects of cytotoxic chemotherapy in patients with high grade gliomas. Brain Tumor Res Treat. 2022;10:158–63.
Chang YC, Liu CL, Chen MJ, Hsu YW, Chen SN, Lin CH, Chen CM, Yang FM, Hu MC. Local anesthetics induce apoptosis in human breast tumor cells. Anesth Analg. 2014;118:116–24.
Johnson MZ, Crowley PD, Foley AG, Xue C, Connolly C, Gallagher HC, Buggy DJ. Effect of perioperative lidocaine on metastasis after sevoflurane or ketamine–xylazine anaesthesia for breast tumour resection in a murine model. Br J Anaesth. 2018;121:76–85.
Zimmitti G, Soliz J, Aloia TA, Gottumukkala V, Cata JP, Tzeng CW, Vauthey JN. Positive impact of epidural analgesia on oncologic outcomes in patients undergoing resection of colorectal liver metastases. Ann Surg Oncol. 2016;23:1003–11.
Xing W, Chen DT, Pan JH, Chen YH, Yan Y, Li Q, Xue RF, Yuan YF, Zeng WA. Lidocaine induces apoptosis and suppresses tumor growth in human hepatocellular carcinoma cells in vitro and in a xenograft model in vivo. Anesthesiology. 2017;126:868–81.
Dersh D, Phelan JD, Gumina ME, Wang B, Arbuckle JH, Holly J, Kishton RJ, Markowitz TE, Seedhom MO, Fridlyand N, et al. Genome-wide screens identify lineage- and tumor-specific genes modulating MHC-I- and MHC-II-restricted immunosurveillance of human lymphomas. Immunity. 2021;54:116-131.e110.
McGranahan N, Rosenthal R, Hiley CT, Rowan AJ, Watkins TBK, Wilson GA, Birkbak NJ, Veeriah S, Van Loo P, Herrero J, et al. Allele-specific HLA loss and immune escape in lung cancer evolution. Cell. 2017;171:1259-1271.e1211.
Yamamoto K, Venida A, Yano J, Biancur DE, Kakiuchi M, Gupta S, Sohn ASW, Mukhopadhyay S, Lin EY, Parker SJ, et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581:100–5.
Zhang J, Zhu S, Tan Q, Cheng D, Dai Q, Yang Z, Zhang L, Li F, Zuo Y, Dai W, et al. Combination therapy with ropivacaine-loaded liposomes and nutrient deprivation for simultaneous cancer therapy and cancer pain relief. Theranostics. 2020;10:4885–99.
Matthew JE, Nazario YL, Roberts SC, Bhatia SR. Effect of mammalian cell culture medium on the gelation properties of Pluronic F127. Biomaterials. 2002;23:4615–9.
Chung CK, Fransen MF, van der Maaden K, Campos Y, Garcia-Couce J, Kralisch D, Chan A, Ossendorp F, Cruz LJ. Thermosensitive hydrogels as sustained drug delivery system for CTLA-4 checkpoint blocking antibodies. J Control Release. 2020;323:1–11.
Shimoyama M, Tatsuoka H, Ohtori S, Tanaka K, Shimoyama N. Change of dorsal horn neurochemistry in a mouse model of neuropathic cancer pain. Pain. 2005;114:221–30.
Lin J, Huang Z, Wu H, Zhou W, Jin P, Wei P, Zhang Y, Zheng F, Zhang J, Xu J, et al. Inhibition of autophagy enhances the anticancer activity of silver nanoparticles. Autophagy. 2014;10:2006–20.
Yu JL, Rak JW, Coomber BL, Hicklin DJ, Kerbel RS. Effect of p53 status on tumor response to antiangiogenic therapy. Science. 2002;295:1526–8.
Ouyang Y, Zhao Y, Zheng X, Zhang Y, Zhao J, Wang S, Gu Y. Rapidly degrading and mussel-inspired multifunctional carboxymethyl chitosan/montmorillonite hydrogel for wound hemostasis. Int J Biol Macromol. 2023;242: 124960.
Remeniuk B, Sukhtankar D, Okun A, Navratilova E, Xie JY, King T, Porreca F. Behavioral and neurochemical analysis of ongoing bone cancer pain in rats. Pain. 2015;156:1864–73.
Kawasaki Y, Kohno T, Zhuang ZY, Brenner GJ, Wang H, Van Der Meer C, Befort K, Woolf CJ, Ji RR. Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization. J Neurosci. 2004;24:8310–21.
Ji RR, Woolf CJ. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis. 2001;8:1–10.
Huang X, Zhang X, Bai X, Liang T. Eating self for not be eaten: pancreatic cancer suppresses self-immunogenicity by autophagy-mediated MHC-I degradation. Signal Transduct Target Ther. 2020;5:94.
Levi JA. The chemotherapy of solid tumours. Med J Aust. 1978;1:15–7.
Cavaletti G. Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know. J Peripher Nerv Syst. 2014;19:66–76.
Song M, Cui M, Liu K. Therapeutic strategies to overcome cisplatin resistance in ovarian cancer. Eur J Med Chem. 2022;232:114205.
Shahid F, Farooqui Z, Khan F. Cisplatin-induced gastrointestinal toxicity: an update on possible mechanisms and on available gastroprotective strategies. Eur J Pharmacol. 2018;827:49–57.
Amable L. Cisplatin resistance and opportunities for precision medicine. Pharmacol Res. 2016;106:27–36.
Yu Y, Fan P, Li J, Wang S. Preparation of biocompatible manganese selenium-based nanoparticles with antioxidant and catalytic functions. Molecules. 2023;28:4498.
Shriky B, Kelly A, Isreb M, Babenko M, Mahmoudi N, Rogers S, Shebanova O, Snow T, Gough T. Pluronic F127 thermosensitive injectable smart hydrogels for controlled drug delivery system development. J Colloid Interface Sci. 2020;565:119–30.
Xiao Y, Gu Y, Qin L, Chen L, Chen X, Cui W, Li F, Xiang N, He X. Injectable thermosensitive hydrogel-based drug delivery system for local cancer therapy. Colloids Surf B Biointerfaces. 2021;200: 111581.
Tang J, Yi W, Yan J, Chen Z, Fan H, Zaldivar-Silva D, Aguero L, Wang S. Highly absorbent bio-sponge based on carboxymethyl chitosan/poly-gamma-glutamic acid/platelet-rich plasma for hemostasis and wound healing. Int J Biol Macromol. 2023;247: 125754.
Zhuang ZY, Gerner P, Woolf CJ, Ji RR. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain. 2005;114:149–59.
Canta A, Pozzi E, Carozzi VA. Mitochondrial dysfunction in chemotherapy-induced peripheral neuropathy (CIPN). Toxics. 2015;3:198–223.
Trecarichi A, Flatters SJL. Mitochondrial dysfunction in the pathogenesis of chemotherapy-induced peripheral neuropathy. Int Rev Neurobiol. 2019;145:83–126.
Park JH, Seo YH, Jang JH, Jeong CH, Lee S, Park B. Asiatic acid attenuates methamphetamine-induced neuroinflammation and neurotoxicity through blocking of NF-kB/STAT3/ERK and mitochondria-mediated apoptosis pathway. J Neuroinflamm. 2017;14:240.
Park JH, Ko J, Park YS, Park J, Hwang J, Koh HC. Clearance of damaged Mitochondria through PINK1 stabilization by JNK and ERK MAPK signaling in chlorpyrifos-treated neuroblastoma cells. Mol Neurobiol. 2017;54:1844–57.
Huang W, Huang J, Jiang Y, Huang X, Xing W, He Y, Ouyang H. Oxaliplatin regulates chemotherapy induced peripheral neuropathic pain in the dorsal horn and dorsal root Ganglion via the calcineurin/NFAT pathway. Anticancer Agents Med Chem. 2018;18:1197–207.
Maruta T, Nemoto T, Hidaka K, Koshida T, Shirasaka T, Yanagita T, Takeya R, Tsuneyoshi I. Upregulation of ERK phosphorylation in rat dorsal root ganglion neurons contributes to oxaliplatin-induced chronic neuropathic pain. PLoS ONE. 2019;14: e0225586.
Nemoto T, Miyazaki S, Kanai T, Maruta T, Satoh S, Yoshikawa N, Yanagita T, Wada A. Nav1.7-Ca2+ influx-induced increased phosphorylations of extracellular signal-regulated kinase (ERK) and p38 attenuate tau phosphorylation via glycogen synthase kinase-3beta: priming of Nav1.7 gating by ERK and p38. Eur J Pharmacol. 2010;640:20–8.
Lee JH, Choi JH, Kim J, Kim TW, Kim JY, Chung G, Cho IH, Jang DS, Kim SK. Syringaresinol alleviates oxaliplatin-induced neuropathic pain symptoms by inhibiting the inflammatory responses of spinal microglia. Molecules. 2022;27:8138.
Song Z, Xiong B, Zheng H, Manyande A, Guan X, Cao F, Ren L, Zhou Y, Ye D, Tian Y. STAT1 as a downstream mediator of ERK signaling contributes to bone cancer pain by regulating MHC II expression in spinal microglia. Brain Behav Immun. 2017;60:161–73.
Zhao M, Zhu S, Zhang D, Zhou C, Yang Z, Wang C, Liu X, Zhang J. Long-lasting postoperative analgesia with local anesthetic-loaded hydrogels prevent tumor recurrence via enhancing CD8(+)T cell infiltration. J Nanobiotechnol. 2023;21:50.
Zhang J, Zhu S, Zhao M, Zhou M, Zhu X, Qing X, Yang Z, Wei P, Zhang G, He W, et al. Analgesic and potentiated photothermal therapy with ropivacaine-loaded hydrogels. Theranostics. 2023;13:2226–40.
